Skip to main content

Table 2 CR Rate: Univariate and Multivariate Analyses for All Patients (N = 46)

From: Histone H4 acetylation by immunohistochemistry and prognosis in newly diagnosed adult acute lymphoblastic leukemia (ALL) patients

Patient Characteristic Odds Ratio (OR) on Univariate Analysis (95% confidence interval with p-value) OR on Multivariate Analysis (95% confidence interval with p-value)
Histone acetylation (Positive versus negative) 2.24 (0.95-5.28), p = 0.07 2.09 (0.87-5.07), p = 0.10
Age (>35 years vs. ≤35 years) 0.67 (0.32-1.39), p = 0.28 0.77 (0.28-2.12), p = 0.61
White blood count (>20,000/μL versus ≤20,000/μL) 1.01 (0.47-2.18), p = 0.98 1.18 (0.33-4.26), p = 0.80
Poor risk cytogenetics versus others 0.89 (0.41-1.90), p = 0.76